Search by Drug Name or NDC
NDC 00713-0536-12 PROMETHEGAN 12.5 mg/1 Details
PROMETHEGAN 12.5 mg/1
PROMETHEGAN is a RECTAL SUPPOSITORY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is PROMETHAZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Promethazine is used to relieve the symptoms of allergic reactions such as allergic rhinitis (runny nose and watery eyes caused by allergy to pollen, mold or dust), allergic conjunctivitis (red, watery eyes caused by allergies), allergic skin reactions, and allergic reactions to blood or plasma products. Promethazine is used with other medications to treat anaphylaxis (sudden, severe allergic reactions) and the symptoms of the common cold such as sneezing, cough, and runny nose. Promethazine is also used to relax and sedate patients before and after surgery, during labor, and at other times. Promethazine is also used to prevent and control nausea and vomiting that may occur after surgery, and with other medications to help relieve pain after surgery. Promethazine is also used to prevent and treat motion sickness. Promethazine helps control symptoms, but will not treat the cause of the symptoms or speed recovery. Promethazine is in a class of medications called phenothiazines. It works by blocking the action of a certain natural substance in the body.
Related Packages: 00713-0536-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Promethazine
Product Information
| NDC | 00713-0536 |
|---|---|
| Product ID | 0713-0536_0b622b7b-a45f-eab0-e063-6394a90a0c0a |
| Associated GPIs | 41400020105205 |
| GCN Sequence Number | 003872 |
| GCN Sequence Number Description | promethazine HCl SUPP.RECT 12.5 MG RECTAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 15003 |
| HICL Sequence Number | 012014 |
| HICL Sequence Number Description | PROMETHAZINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | PROMETHEGAN |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | promethazine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUPPOSITORY |
| Route | RECTAL |
| Active Ingredient Strength | 12.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | PROMETHAZINE HYDROCHLORIDE |
| Labeler Name | Cosette Pharmaceuticals, Inc. |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040428 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00713-0536-12 (00713053612)
| NDC Package Code | 0713-0536-12 |
|---|---|
| Billing NDC | 00713053612 |
| Package | 12 SUPPOSITORY in 1 BOX (0713-0536-12) |
| Marketing Start Date | 2004-02-28 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 3.5226 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PROMETHEGAN 12.5 MG SUPPOS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |